Your browser doesn't support javascript.
loading
Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire.
Saketkoo, Lesley Ann; Gordon, Jessica K; Fligelstone, Kim; Mawdsley, Anne; Chaudhry, Humza A; Valenzuela, Antonia; Christensen, Angela; Khalique, Samara M; Jensen, Kelly; Weinmann, Sophia C; Busman, Evan; Chung, Lorinda; Hsu, Vivien M; Russell, Anne-Marie; Steen, Virginia D.
Afiliação
  • Saketkoo LA; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, USA; University Medical Center-Comprehensive Pulmonary Hypertension Center and Interstitial Lung Disease Clinic Programs, New Orleans, LA, USA; Section of Pulmonary Medicine, Louisiana State University School
  • Gordon JK; Department of Rheumatology, Hospital for Special Surgery, New York, NY, USA.
  • Fligelstone K; Scleroderma & Raynaud Society, UK (SRUK); Federation of European Scleroderma Associations, UK.
  • Mawdsley A; Raynaud's & Scleroderma Association-Care and Support, London, UK.
  • Chaudhry HA; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, USA; Tulane University School of Medicine, New Orleans, LA, USA.
  • Valenzuela A; Department of Rheumatology and Clinical Immunology, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Christensen A; Doctors Hospital, Renaissance, TX, USA.
  • Khalique SM; Department of Rheumatology, Virginia Tech Carilion Clinic School of Medicine, Roanoke, VA, USA.
  • Jensen K; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, USA; Tulane University School of Medicine, New Orleans, LA, USA; University of Colorado School of Medicine, Denver, CO, USA.
  • Weinmann SC; Department of Medicine, Division of Rheumatology and Immunology, Duke University Hospital, Durham, NC, USA.
  • Busman E; Healthcare Patient Advocate, Atlanta, GA, USA.
  • Chung L; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine and Palo Alto VA Healthcare System, Palo Alto, CA, USA; Department of Dermatology, Division of Immunology and Rheumatology, Stanford University School of Medicine and Palo Alto VA Healthcare Syste
  • Hsu VM; RWJ-Scleroderma Program, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Russell AM; Respiratory Institute, University of Exeter, Exeter, UK; Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, UK.
  • Steen VD; Division of Rheumatology, Department of Medicine, Georgetown University, Washington, DC, USA.
Rheum Dis Clin North Am ; 49(2): 463-481, 2023 05.
Article em En | MEDLINE | ID: mdl-37028847
ABSTRACT
Systemic sclerosis (SSc) -related calcinosis can be a debilitating, constantly painful, poorly understood vascular complication of calcium hydroxyapatite deposition in soft tissue structures that affects approximately 40% of both limited and diffuse cutaneous SSc subtypes. This publication describes the iterative and multitiered international qualitative investigations that yielded remarkable insights into natural history, daily experience, and complications of SSc-calcinosis providing pivotal information for health management. Patient-driven question development and field testing, according to Food and Drug Administration guidance, propelled the development of a patient-reported outcome measure for SSc-calcinosis, the Mawdsley Calcinosis Questionnaire.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Calcinose Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Calcinose Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article